Open AccessMO533: Safety of Roxadustat versus Erythropoiesis-Stimulating Agents for Treatment of Anemia in Patients With Chronic Kidney Disease Incident to or not Receiving Dialysis: Pooled Analysis of Four Phase 3 Studies
Author(s) -
Jonathan Barratt,
Frank Dellanna,
José Pórtoles,
Gabriel Choukroun,
Luca De Nicola,
Michael Reusch,
James Young,
Nada Dimković
Publication year - 2022
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfac072.015
Subject(s) - mace , medicine , hazard ratio , anemia , dialysis , kidney disease , heart failure , myocardial infarction , population , adverse effect , confidence interval , percutaneous coronary intervention , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom